U.S-South Africa Program for Collaborative Biomedical Research (R21)

 

The purpose of this Funding Opportunity Announcement (FOA) is to establish a new U.S.-South Africa Program for Collaborative Biomedical Research. Research areas supported under this program include TB, HIV/AIDS biomedical and behavioral science, and HIV-related co-morbidities, including malignancies.

Deleted 05/23/2014 (Archived.) RFA-AI-14-010 Agency: Department of Health and Human Services
Office: National Institutes of Health Grant Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) from South Africa are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 04/22/2014 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-010.html FBOWebmaster@OD.NIH.GOV $8,000,000.00 Awards up to $200,000.00